{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:14:21Z","timestamp":1789103661585,"version":"build-2803163510"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Russian Science Foundation Funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s43032-022-01013-x","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T21:02:41Z","timestamp":1656450161000},"page":"772-786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Updates on Molecular Targets and Epigenetic-Based Therapies for PCOS"],"prefix":"10.1007","volume":"30","author":[{"given":"Viktor V.","family":"Smirnov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6879-7835","authenticated-orcid":false,"given":"Narasimha M.","family":"Beeraka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry Yu","family":"Butko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir N.","family":"Nikolenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey A.","family":"Bondarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeniy E.","family":"Achkasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail Y.","family":"Sinelnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. R. Hemanth","family":"Vikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"issue":"1","key":"1013_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6\u201315.","journal-title":"Fertil Steril"},{"key":"1013_CR2","unstructured":"Nadelyaeva YG, Suturina L: Polycystic ovary syndrome and menopause."},{"issue":"11","key":"1013_CR3","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3390\/nu11112711","volume":"11","author":"AW Lin","year":"2019","unstructured":"Lin AW, Kazemi M, Jarrett BY, Vanden Brink H, Hoeger KM, Spandorfer SD, Lujan ME. Dietary and physical activity behaviors in women with polycystic ovary syndrome per the new international evidence-based guideline. Nutrients. 2019;11(11):2711.","journal-title":"Nutrients"},{"key":"1013_CR4","doi-asserted-by":"crossref","unstructured":"Group REASPCW Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human reproduction 2004, 19(1):41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"1013_CR5","doi-asserted-by":"crossref","unstructured":"Rojas J, Ch\u00e1vez M, Olivar L, Rojas M, Morillo J, Mej\u00edas J, Calvo M, Berm\u00fadez V: Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. International journal of reproductive medicine 2014, 2014.","DOI":"10.1155\/2014\/719050"},{"issue":"4","key":"1013_CR6","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-14-0253","volume":"171","author":"G Conway","year":"2014","unstructured":"Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 2014;171(4):P1\u201329.","journal-title":"Eur J Endocrinol"},{"key":"1013_CR7","unstructured":"Anvar MAS: Polycystic ovarian syndrome (PCOS). Five-minute Consult Clinical Companion to Women\u2019s Health 2007:217."},{"key":"1013_CR8","unstructured":"Ta\u0439\u0446 AH, Bopo\u0431\u0446o\u0432a \u0418H, \u041ayp\u0434\u044b\u043d\u043ao \u041bB, C\u043c\u0438p\u043do\u0432 BB, \u0428a\u043fo\u0432a\u043bo\u0432a A\u0411, \u0426ep\u0446\u0432a\u0434\u0437e \u0413\u041a: \u041fa\u0442o\u0444\u0438\u0437\u0438o\u043bo\u0433\u0438\u0447ec\u043a\u0438e ac\u043fe\u043a\u0442\u044b \u0444op\u043c\u0438po\u0432a\u043d\u0438\u044f \u0438\u043dcy\u043b\u0438\u043dope\u0437\u0438c\u0442e\u043d\u0442\u043doc\u0442\u0438 y \u0436e\u043d\u0449\u0438\u043d c c\u0438\u043d\u0434po\u043co\u043c \u043fo\u043b\u0438\u043a\u0438c\u0442o\u0437\u043d\u044bx \u044f\u0438\u0447\u043d\u0438\u043ao\u0432.Me\u0434\u0438\u0446\u0438\u043da: \u0442eop\u0438\u044f \u0438 \u043fpa\u043a\u0442\u0438\u043aa 2018, 3(2)."},{"key":"1013_CR9","unstructured":"\u0417axapo\u0432 \u0418C, \u0411y\u043apee\u0432a E: O\u043ac\u0438\u0434a\u0442\u0438\u0432\u043d\u044b\u0439 c\u0442pecc \u043fp\u0438 c\u0438\u043d\u0434po\u043ce \u043fo\u043b\u0438\u043a\u0438c\u0442o\u0437\u043d\u044bx \u044f\u0438\u0447\u043d\u0438\u043ao\u0432: \u043fpo\u0433\u043doc\u0442\u0438\u0447ec\u043aoe \u0437\u043da\u0447e\u043d\u0438e, \u0432o\u0437\u043co\u0436\u043doc\u0442\u0438 \u043aoppe \u043a\u0446\u0438\u0438. \u0413\u0438\u043de\u043ao\u043bo\u0433\u0438\u044f 2018, 20(1)."},{"key":"1013_CR10","unstructured":"\u041ay\u0437\u044c\u043ci\u043da I\u042e, \u0416y\u043bi\u043ao\u0432a MB \u0414ia\u0433\u043doc\u0442\u0438\u0447\u043di \u043ap\u0438\u0442epi\u0457 c\u0438\u043d\u0434po\u043cy \u043fo\u043bi\u043aic\u0442o\u0437\u043d\u0438x \u044f\u0454\u0447\u043d\u0438\u043ai\u0432. Mi\u0436\u043dapo\u0434\u043d\u0438\u0439 \u043ce\u0434\u0438\u0447\u043d\u0438\u0439 \u0436yp\u043da\u043b 2018(24,\u2116 3):37\u201339."},{"key":"1013_CR11","first-page":"103","volume":"7","author":"A Javed","year":"2015","unstructured":"Javed A, Kashyap R, Lteif AN. Hyperandrogenism in female athletes with functional hypothalamic amenorrhea: a distinct phenotype. Int J women\u2019s health. 2015;7:103.","journal-title":"Int J women\u2019s health"},{"issue":"5","key":"1013_CR12","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.fertnstert.2014.08.001","volume":"102","author":"NM Daan","year":"2014","unstructured":"Daan NM, Louwers YV, Koster MP, Eijkemans MJ, de Rijke YB, Lentjes EW, Fauser BC, Laven JS. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes who is really at risk? Fertility and sterility. 2014;102(5):1444-1451 e1443.","journal-title":"Fertility and sterility"},{"issue":"10","key":"1013_CR13","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.amjmed.2014.04.017","volume":"127","author":"TL Setji","year":"2014","unstructured":"Setji TL, Brown AJ. Polycystic ovary syndrome: update on diagnosis and treatment. Am J Med. 2014;127(10):912\u20139.","journal-title":"Am J Med"},{"issue":"11","key":"1013_CR14","doi-asserted-by":"publisher","first-page":"E2269","DOI":"10.1210\/jc.2013-3942","volume":"99","author":"Z Niu","year":"2014","unstructured":"Niu Z, Lin N, Gu R, Sun Y, Feng Y. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J Clin Endocrinol Metab. 2014;99(11):E2269\u201376.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1013_CR15","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.3390\/nu11092055","volume":"11","author":"C Stefanaki","year":"2019","unstructured":"Stefanaki C, Bacopoulou F, Kandaraki E, Boschiero D, Diamandi-Kandarakis E. Lean women on metformin and oral contraceptives for polycystic ovary syndrome demonstrate a dehydrated osteosarcopenic phenotype: a pilot study. Nutrients. 2019;11(9):2055.","journal-title":"Nutrients"},{"issue":"1","key":"1013_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"TR Eshre","year":"2004","unstructured":"Eshre TR. Group A-SPCW: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and sterility. 2004;81(1):19\u201325.","journal-title":"Fertility and sterility"},{"key":"1013_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000321974","volume":"55","author":"JL Scheid","year":"2010","unstructured":"Scheid JL, De Souza MJ. Menstrual irregularities and energy deficiency in physically active women: the role of ghrelin, PYY and adipocytokines. Cytokines, Growth Mediators Phys Activity Children Puberty. 2010;55:82\u2013102.","journal-title":"Cytokines, Growth Mediators Phys Activity Children Puberty"},{"issue":"1","key":"1013_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-018-0437-8","volume":"16","author":"S La Vignera","year":"2018","unstructured":"La Vignera S, Condorelli RA, Cannarella R, Duca Y, Calogero AE. Sport, doping and female fertility. Reprod Biol Endocrinol. 2018;16(1):1\u201310.","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"1013_CR19","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S1701-2163(16)32661-5","volume":"29","author":"CN Mircea","year":"2007","unstructured":"Mircea CN, Lujan ME, Pierson RA. Metabolic fuel and clinical implications for female reproduction. J Obstet Gynaecol Can. 2007;29(11):887\u2013902.","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"1013_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s12020-012-9655-6","volume":"42","author":"L Di Luigi","year":"2012","unstructured":"Di Luigi L, Romanelli F, Sgr\u00f2 P, Lenzi A. Andrological aspects of physical exercise and sport medicine. Endocrine. 2012;42(2):278\u201384.","journal-title":"Endocrine"},{"issue":"4","key":"1013_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3109\/13685538.2010.544344","volume":"14","author":"S La Vignera","year":"2011","unstructured":"La Vignera S, Condorelli R, Vicari E, D\u2019agata R, Calogero A. Aerobic physical activity improves endothelial function in the middle-aged patients with erectile dysfunction. Aging Male. 2011;14(4):265\u201372.","journal-title":"Aging Male"},{"issue":"2","key":"1013_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2164\/jandrol.111.013649","volume":"33","author":"S La Vignera","year":"2012","unstructured":"La Vignera S, Condorelli R, Vicari E, D\u2019Agata R, Calogero AE. Physical activity and erectile dysfunction in middle-aged men. Journal of andrology. 2012;33(2):154\u201361.","journal-title":"Journal of andrology"},{"key":"1013_CR23","unstructured":"Zawadeski J, Dunaif A: Diagnostic criteria for PCOS: towards a more rational approach. PCOS Boston: Blackwell Scientific 1992:377\u2013384."},{"issue":"2","key":"1013_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE. The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456\u201388.","journal-title":"Fertil Steril"},{"issue":"1","key":"1013_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and sterility. 2012;97(1):28-38e25.","journal-title":"Fertility and sterility"},{"issue":"2","key":"1013_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.fertnstert.2018.10.011","volume":"111","author":"N Crisosto","year":"2019","unstructured":"Crisosto N, de Guevara AL, Echibur\u00fa B, Maliqueo M, Cavada G, Codner E, Paez F, Sir-Petermann T. Higher luteinizing hormone levels associated with Antim\u00fcllerian hormone in postmenarchal daughters of women with polycystic ovary syndrome. Fertil Steril. 2019;111(2):381\u20138.","journal-title":"Fertil Steril"},{"issue":"12","key":"1013_CR27","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","volume":"25","author":"S Risal","year":"2019","unstructured":"Risal S, Pei Y, Lu H, Manti M, Fornes R, Pui H-P, Zhao Z, Massart J, Ohlsson C, Lindgren E. Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nat Med. 2019;25(12):1894\u2013904.","journal-title":"Nat Med"},{"issue":"1\u20132","key":"1013_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mce.2012.10.005","volume":"373","author":"V Padmanabhan","year":"2013","unstructured":"Padmanabhan V, Veiga-Lopez A. Sheep models of polycystic ovary syndrome phenotype. Mol Cell Endocrinol. 2013;373(1\u20132):8\u201320.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"1013_CR29","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","volume":"24","author":"B Tata","year":"2018","unstructured":"Tata B, Mimouni NEH, Barbotin A-L, Malone SA, Loyens A, Pigny P, Dewailly D, Catteau-Jonard S, Sundstr\u00f6m-Poromaa I, Piltonen TT. Elevated prenatal anti-M\u00fcllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med. 2018;24(6):834\u201346.","journal-title":"Nat Med"},{"issue":"3","key":"1013_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2021.01.004","volume":"33","author":"NEH Mimouni","year":"2021","unstructured":"Mimouni NEH, Paiva I, Barbotin A-L, Timzoura FE, Plassard D, Le Gras S, Ternier G, Pigny P, Catteau-Jonard S, Simon V. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell metabolism. 2021;33(3):513-530.e518.","journal-title":"Cell metabolism"},{"issue":"1","key":"1013_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-016-0173-x","volume":"14","author":"V De Leo","year":"2016","unstructured":"De Leo V, Musacchio M, Cappelli V, Massaro M, Morgante G, Petraglia F. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol. 2016;14(1):1\u201317.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"1013_CR32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMcp1514916","volume":"375","author":"CR McCartney","year":"2016","unstructured":"McCartney CR, Marshall JC. Polycystic ovary syndrome. N Engl J Med. 2016;375(1):54\u201364.","journal-title":"N Engl J Med"},{"issue":"2","key":"1013_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0973-6883(12)60102-9","volume":"2","author":"A Mishra","year":"2012","unstructured":"Mishra A, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. J Clin Exp Hepatol. 2012;2(2):135\u201344.","journal-title":"J Clin Exp Hepatol"},{"issue":"12","key":"1013_CR34","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","volume":"40","author":"A Rocha","year":"2017","unstructured":"Rocha A, Faria L, Guimar\u00e3es T, Moreira G, C\u00e2ndido A, Couto C, Reis F. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. J Endocrinol Invest. 2017;40(12):1279\u201388.","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"1013_CR35","doi-asserted-by":"publisher","first-page":"R219","DOI":"10.1530\/REP-14-0435","volume":"149","author":"PM Spritzer","year":"2015","unstructured":"Spritzer PM, Lecke SB, Satler F, Morsch DM. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015;149(5):R219\u201327.","journal-title":"Reproduction"},{"issue":"5","key":"1013_CR36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s40618-016-0582-x","volume":"40","author":"U Durmus","year":"2017","unstructured":"Durmus U, Duran C, Ecirli S. Visceral adiposity index levels in overweight and\/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters. J Endocrinol Invest. 2017;40(5):487\u201397.","journal-title":"J Endocrinol Invest"},{"issue":"7382","key":"1013_CR37","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostr\u00f6m EA, Choi JH, Long JZ. A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463\u20138.","journal-title":"Nature"},{"issue":"2","key":"1013_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s12020-017-1476-1","volume":"59","author":"SA Polyzos","year":"2018","unstructured":"Polyzos SA, Anastasilakis AD, Efstathiadou ZA, Makras P, Perakakis N, Kountouras J, Mantzoros CS. Irisin in metabolic diseases. Endocrine. 2018;59(2):260\u201374.","journal-title":"Endocrine"},{"issue":"39","key":"1013_CR39","doi-asserted-by":"publisher","first-page":"12157","DOI":"10.1073\/pnas.1516622112","volume":"112","author":"G Colaianni","year":"2015","unstructured":"Colaianni G, Cuscito C, Mongelli T, Pignataro P, Buccoliero C, Liu P, Lu P, Sartini L, Di Comite M, Mori G. The myokine irisin increases cortical bone mass. Proc Natl Acad Sci. 2015;112(39):12157\u201362.","journal-title":"Proc Natl Acad Sci"},{"key":"1013_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neulet.2018.04.023","volume":"676","author":"N Uysal","year":"2018","unstructured":"Uysal N, Yuksel O, Kizildag S, Yuce Z, Gumus H, Karakilic A, Guvendi G, Koc B, Kandis S, Ates M. Regular aerobic exercise correlates with reduced anxiety and incresed levels of irisin in brain and white adipose tissue. Neurosci Lett. 2018;676:92\u20137.","journal-title":"Neurosci Lett"},{"issue":"1","key":"1013_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41591-018-0275-4","volume":"25","author":"MV Lourenco","year":"2019","unstructured":"Lourenco MV, Frozza RL, de Freitas GB, Zhang H, Kincheski GC, Ribeiro FC, Gon\u00e7alves RA, Clarke JR, Beckman D, Staniszewski A. Exercise-linked FNDC5\/irisin rescues synaptic plasticity and memory defects in Alzheimer\u2019s models. Nat Med. 2019;25(1):165\u201375.","journal-title":"Nat Med"},{"issue":"4","key":"1013_CR42","doi-asserted-by":"publisher","first-page":"E769","DOI":"10.1210\/jc.2012-2749","volume":"98","author":"JM Moreno-Navarrete","year":"2013","unstructured":"Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, Fern\u00e1ndez-Real JM. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013;98(4):E769\u201378.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1013_CR43","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s40618-018-0902-4","volume":"41","author":"L Zhang","year":"2018","unstructured":"Zhang L, Fang X, Li L, Liu R, Zhang C, Liu H, Tan M, Yang G. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome. J Endocrinol Invest. 2018;41(12):1401\u20137.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1013_CR44","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.rbmo.2017.10.114","volume":"36","author":"X Cai","year":"2018","unstructured":"Cai X, Qiu S, Li L, Zuegel M, Steinacker JM, Schumann U. Circulating irisin in patients with polycystic ovary syndrome: a meta-analysis. Reprod Biomed Online. 2018;36(2):172\u201380.","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"1013_CR45","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.3390\/nu7064555","volume":"7","author":"C He","year":"2015","unstructured":"He C, Lin Z, Robb SW, Ezeamama AE. Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis. Nutrients. 2015;7(6):4555\u201377.","journal-title":"Nutrients"},{"issue":"6","key":"1013_CR46","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/cen.12840","volume":"83","author":"F Foroozanfard","year":"2015","unstructured":"Foroozanfard F, Jamilian M, Bahmani F, Talaee R, Talaee N, Hashemi T, Nasri K, Asemi Z, Esmaillzadeh A. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Clin Endocrinol. 2015;83(6):888\u201394.","journal-title":"Clin Endocrinol"},{"issue":"11","key":"1013_CR47","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1210\/jc.2015-2580","volume":"100","author":"M Irani","year":"2015","unstructured":"Irani M, Seifer DB, Grazi RV, Julka N, Bhatt D, Kalgi B, Irani S, Tal O, Lambert-Messerlian G, Tal R. Vitamin D supplementation decreases TGF-\u03b21 bioavailability in PCOS: a randomized placebo-controlled trial. J Clin Endocrinol Metab. 2015;100(11):4307\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"1013_CR48","unstructured":"Co\u0431o\u043be\u0432a E: Coc\u0442o\u044f\u043d\u0438e y\u0433\u043be\u0432o\u0434\u043do\u0433o o\u0431\u043ce\u043da \u043fp\u0438 c\u0438\u043d\u0434po\u043ce \u043fo\u043b\u0438\u043a\u0438c\u0442o\u0437\u043d\u044bx \u044f\u0438\u0447\u043d\u0438\u043ao\u0432. \u041fpo\u0431\u043be\u043c\u044b \u044d\u043d\u0434o\u043ap\u0438\u043do\u043bo\u0433\u0438\u0438 2012, 58(5)."},{"issue":"5","key":"1013_CR49","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/sms.13385","volume":"29","author":"EM Brook","year":"2019","unstructured":"Brook EM, Tenforde AS, Broad EM, Matzkin EG, Yang HY, Collins JE, Blauwet CA. Low energy availability, menstrual dysfunction, and impaired bone health: A survey of elite para athletes. Scand J Med Sci Sports. 2019;29(5):678\u201385.","journal-title":"Scand J Med Sci Sports"},{"key":"1013_CR50","unstructured":"\u0423p\u043ca\u043do\u0432a \u042e, Xa\u043b\u0438\u043co\u0432a \u0417, Xo\u0434\u0436ae\u0432a \u0424, A\u043b\u0438e\u0432a \u0414, Co\u0434\u0438\u043ao\u0432 C, Ha\u0431\u0438e\u0432a \u0418, Ca\u0432\u0447y\u043a \u0414, \u041aap\u0438\u043co\u0432a M: \u0424y\u043d\u043a\u0446\u0438o\u043da\u043b\u044c\u043doe coc\u0442o\u044f\u043d\u0438e oc\u0438 \u00ab\u0413\u0438\u043fo\u0444\u0438\u0437\u2014\u0433o\u043da\u0434\u044b\u00bb y \u0436e\u043d\u0449\u0438\u043d c c\u0438\u043d\u0434po\u043co\u043c \u043fo\u043b\u0438\u043a\u0438c\u0442o\u0437\u043d\u044bx \u044f\u0438\u0447\u043d\u0438\u043ao\u0432. Me\u0436\u0434y\u043dapo\u0434\u043d\u044b\u0439 \u044d\u043d\u0434o\u043ap\u0438\u043do\u043bo\u0433\u0438\u0447ec\u043a\u0438\u0439 \u0436yp\u043da\u043b 2016(6 (78))."},{"issue":"6","key":"1013_CR51","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.2337\/db14-1701","volume":"64","author":"AR Konopka","year":"2015","unstructured":"Konopka AR, Asante A, Lanza IR, Robinson MM, Johnson ML, Dalla Man C, Cobelli C, Amols MH, Irving BA, Nair KS. Defects in mitochondrial efficiency and H2O2 emissions in obese women are restored to a lean phenotype with aerobic exercise training. Diabetes. 2015;64(6):2104\u201315.","journal-title":"Diabetes"},{"issue":"4","key":"1013_CR52","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5603\/EP.2018.0046","volume":"69","author":"A Milewicz","year":"2018","unstructured":"Milewicz A, Kud\u0142a M, Spaczy\u0144ski RZ, D\u0119bski R, M\u0119czekalski B, Wielgo\u015b M, Rucha\u0142a M, Ma\u0142ecka-Tendera E, Kos-Kud\u0142a B, J\u0119drzejuk D. The polycystic ovary syndrome: a position statement from the Polish Society of Endocrinology, the Polish Society of Gynaecologists and Obstetricians, and the Polish Society of Gynaecological Endocrinology. Endokrynol Pol. 2018;69(4):328\u201344.","journal-title":"Endokrynol Pol"},{"issue":"2","key":"1013_CR53","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.molcel.2015.12.002","volume":"61","author":"I Mart\u00ednez-Reyes","year":"2016","unstructured":"Mart\u00ednez-Reyes I, Diebold LP, Kong H, Schieber M, Huang H, Hensley CT, Mehta MM, Wang T, Santos JH, Woychik R. TCA cycle and mitochondrial membrane potential are necessary for diverse biological functions. Mol Cell. 2016;61(2):199\u2013209.","journal-title":"Mol Cell"},{"issue":"7","key":"1013_CR54","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1080\/02640414.2015.1065340","volume":"34","author":"EN Muia","year":"2016","unstructured":"Muia EN, Wright HH, Onywera VO, Kuria EN. Adolescent elite Kenyan runners are at risk for energy deficiency, menstrual dysfunction and disordered eating. J Sports Sci. 2016;34(7):598\u2013606.","journal-title":"J Sports Sci"},{"key":"1013_CR55","doi-asserted-by":"crossref","unstructured":"Onyango AN: The contribution of singlet oxygen to insulin resistance. Oxidative medicine and cellular longevity 2017, 2017.","DOI":"10.1155\/2017\/8765972"},{"issue":"9","key":"1013_CR56","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.2337\/db07-0275","volume":"56","author":"V Skov","year":"2007","unstructured":"Skov V, Glintborg D, Knudsen S, Jensen T, Kruse TA, Tan Q, Brusgaard K, Beck-Nielsen H, H\u00f8jlund K. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes. 2007;56(9):2349\u201355.","journal-title":"Diabetes"},{"issue":"3","key":"1013_CR57","first-page":"260","volume":"9","author":"M Gholinezhad","year":"2018","unstructured":"Gholinezhad M, Gholsorkhtabaramiri M, Esmaeilzadeh S, Ghanbarpour A. Insulin resistance and adverse metabolic profile in overweight\/obese and normal weight of young women with polycystic ovary syndrome. Caspian J Intern Med. 2018;9(3):260.","journal-title":"Caspian J Intern Med"},{"issue":"4","key":"1013_CR58","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.steroids.2011.12.003","volume":"77","author":"F Gonz\u00e1lez","year":"2012","unstructured":"Gonz\u00e1lez F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77(4):300\u20135.","journal-title":"Steroids"},{"key":"1013_CR59","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez F: Nutrient-induced inflammation in polycystic ovary syndrome: role in the development of metabolic aberration and ovarian dysfunction. In: Seminars in reproductive medicine: 2015: Thieme Medical Publishers; 2015: 276\u2013286.","DOI":"10.1055\/s-0035-1554918"},{"issue":"304","key":"1013_CR60","doi-asserted-by":"publisher","first-page":"304re307","DOI":"10.1126\/scitranslmed.aac4765","volume":"7","author":"G Boden","year":"2015","unstructured":"Boden G, Homko C, Barrero CA, Stein TP, Chen X, Cheung P, Fecchio C, Koller S, Merali S. Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men. Sci Trans Med. 2015;7(304):304re307-304re307.","journal-title":"Sci Trans Med"},{"issue":"4","key":"1013_CR61","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S0015-0282(02)04850-1","volume":"79","author":"A Rickenlund","year":"2003","unstructured":"Rickenlund A, Carlstr\u00f6m K, J\u00f6rn Ekblom B, Brismar TB, von Schoultz B, Hirschberg AL. Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance. Fertil Steril. 2003;79(4):947\u201355.","journal-title":"Fertil Steril"},{"issue":"9","key":"1013_CR62","first-page":"2740","volume":"80","author":"N Constantini","year":"1995","unstructured":"Constantini N, Warren M. Menstrual dysfunction in swimmers: a distinct entity. J Clin Endocrinol Metab. 1995;80(9):2740\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1013_CR63","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.fertnstert.2011.07.006","volume":"96","author":"O Coste","year":"2011","unstructured":"Coste O, Paris F, Galtier F, Letois F, Ma\u00efmoun L, Sultan C. Polycystic ovary\u2013like syndrome in adolescent competitive swimmers. Fertil Steril. 2011;96(4):1037\u201342.","journal-title":"Fertil Steril"},{"issue":"2","key":"1013_CR64","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1210\/jc.2003-030306","volume":"89","author":"A Rickenlund","year":"2004","unstructured":"Rickenlund A, Thor\u00e9n M, Carlstr\u00f6m K, Von Schoultz B. Hirschberg ALn: Diurnal profiles of testosterone and pituitary hormones suggest different mechanisms for menstrual disturbances in endurance athletes. J Clin Endocrinol Metab. 2004;89(2):702\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1013_CR65","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1249\/MSS.0b013e318195a21a","volume":"41","author":"M Hagmar","year":"2009","unstructured":"Hagmar M, Berglund B, Brismar K, Hirschberg AL. Hyperandrogenism may explain reproductive dysfunction in olympic athletes. Med Sci Sports Exerc. 2009;41(6):1241\u20138.","journal-title":"Med Sci Sports Exerc"},{"issue":"9","key":"1013_CR66","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1517\/14656566.2015.1047344","volume":"16","author":"ML Rocca","year":"2015","unstructured":"Rocca ML, Venturella R, Mocciaro R, Di Cello A, Sacchinelli A, Russo V, Trapasso S, Zullo F, Morelli M. Polycystic ovary syndrome: chemical pharmacotherapy. Expert Opin Pharmacother. 2015;16(9):1369\u201393.","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"1013_CR67","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 1. Endocr Pract. 2015;21(11):1291\u2013300.","journal-title":"Endocr Pract"},{"issue":"11","key":"1013_CR68","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1210\/jc.2014-1391","volume":"99","author":"S Bermon","year":"2014","unstructured":"Bermon S, Garnier PY, Hirschberg AL, Robinson N, Giraud S, Nicoli R, Baume N, Saugy M, F\u00e9nichel P, Bruce SJ. Serum androgen levels in elite female athletes. J Clin Endocrinol Metab. 2014;99(11):4328\u201335.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1013_CR69","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/1933719116670265","volume":"24","author":"S-H Zheng","year":"2017","unstructured":"Zheng S-H, Du D-F, Li X-L. Leptin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Reprod Sci. 2017;24(5):656\u201370.","journal-title":"Reprod Sci"},{"issue":"15","key":"1013_CR70","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jacc.2008.05.060","volume":"52","author":"SS Martin","year":"2008","unstructured":"Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol. 2008;52(15):1201\u201310.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1013_CR71","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 2. Endocr Pract. 2015;21(12):1415\u201326.","journal-title":"Endocr Pract"},{"issue":"3","key":"1013_CR72","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1530\/EJE-13-0797","volume":"170","author":"MJ Sever","year":"2014","unstructured":"Sever MJ, Kocjan T, Pfeifer M, Kravos NA, Janez A. Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin. Eur J Endocrinol. 2014;170(3):451.","journal-title":"Eur J Endocrinol"},{"key":"1013_CR73","doi-asserted-by":"crossref","unstructured":"Baldani DP, Skrgatic L, Ougouag R: Polycystic ovary syndrome: important underrecognised cardiometabolic risk factor in reproductive-age women. International journal of endocrinology 2015, 2015.","DOI":"10.1155\/2015\/786362"},{"issue":"36","key":"1013_CR74","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.2174\/1381612822666160720155855","volume":"22","author":"P Moghetti","year":"2016","unstructured":"Moghetti P. Insulin resistance and polycystic ovary syndrome. Curr Pharm Des. 2016;22(36):5526\u201334.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"1013_CR75","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1530\/EJE-13-1007","volume":"171","author":"S Livadas","year":"2014","unstructured":"Livadas S, Kollias A, Panidis D, Diamanti-Kandarakis E. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome. Eur J Endocrinol. 2014;171(3):301\u20139.","journal-title":"Eur J Endocrinol"},{"key":"1013_CR76","doi-asserted-by":"crossref","unstructured":"Lepine S, Jo J, Metwally M, Cheong YC: Ovarian surgery for symptom relief in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2017(11).","DOI":"10.1002\/14651858.CD009526.pub2"},{"issue":"7","key":"1013_CR77","doi-asserted-by":"publisher","first-page":"R238","DOI":"10.1530\/EC-18-0129","volume":"7","author":"KB Studen","year":"2018","unstructured":"Studen KB, Pfeifer M. Cardiometabolic risk in polycystic ovary syndrome. Endocr Connect. 2018;7(7):R238\u201351.","journal-title":"Endocr Connect"},{"key":"1013_CR78","unstructured":"\u041ao\u043dpa\u0434\u0438 A, \u0411apa\u043do\u0432a E, \u0426\u044bp\u043b\u0438\u043d B, \u041aopoc\u0442o\u0432\u0446e\u0432a \u041b, Pa\u0442o\u0432a \u041b: AHT\u0418\u0413\u0418\u041fEPTEH\u0417\u0418BHA\u042f \u041b\u0418\u0413A. 2015."},{"issue":"3","key":"1013_CR79","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/1570161114666161221115324","volume":"15","author":"T Tzotzas","year":"2017","unstructured":"Tzotzas T. N Karras S, Katsiki N: Glucagon-like peptide-1 (GLP-1) receptor agonists in the treatment of obese women with polycystic ovary syndrome. Curr Vasc Pharmacol. 2017;15(3):218\u201329.","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"1013_CR80","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1677\/JOE-08-0468","volume":"201","author":"H Liu","year":"2009","unstructured":"Liu H, Dear AE, Knudsen LB, Simpson RW. A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules. J Endocrinol. 2009;201(1):59.","journal-title":"J Endocrinol"},{"issue":"12","key":"1013_CR81","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1210\/en.2019-00450","volume":"160","author":"ED Torres Fernandez","year":"2019","unstructured":"Torres Fernandez ED, Huffman AM, Syed M, Romero DG, Yanes Cardozo LL. Effect of GLP-1 receptor agonists in the cardiometabolic complications in a rat model of postmenopausal PCOS. Endocrinology. 2019;160(12):2787\u201399.","journal-title":"Endocrinology"},{"issue":"5929","key":"1013_CR82","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.1169786","volume":"324","author":"S Kriaucionis","year":"2009","unstructured":"Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science. 2009;324(5929):929\u201330.","journal-title":"Science"},{"issue":"5929","key":"1013_CR83","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324(5929):930\u20135.","journal-title":"Science"},{"issue":"6047","key":"1013_CR84","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1126\/science.1210597","volume":"333","author":"S Ito","year":"2011","unstructured":"Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C, Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011;333(6047):1300\u20133.","journal-title":"Science"},{"issue":"10","key":"1013_CR85","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","volume":"20","author":"MV Greenberg","year":"2019","unstructured":"Greenberg MV. Bourc\u2019his D: The diverse roles of DNA methylation in mammalian development and disease. Nat Rev Mol Cell Biol. 2019;20(10):590\u2013607.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"1013_CR86","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2014.04.017","volume":"157","author":"L Wang","year":"2014","unstructured":"Wang L, Zhang J, Duan J, Gao X, Zhu W, Lu X, Yang L, Zhang J, Li G, Ci W. Programming and inheritance of parental DNA methylomes in mammals. Cell. 2014;157(4):979\u201391.","journal-title":"Cell"},{"issue":"6","key":"1013_CR87","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.cell.2015.04.053","volume":"161","author":"WW Tang","year":"2015","unstructured":"Tang WW, Dietmann S, Irie N, Leitch HG, Floros VI, Bradshaw CR, Hackett JA, Chinnery PF, Surani MA. A unique gene regulatory network resets the human germline epigenome for development. Cell. 2015;161(6):1453\u201367.","journal-title":"Cell"},{"issue":"12","key":"1013_CR88","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s41580-018-0074-2","volume":"19","author":"K Skvortsova","year":"2018","unstructured":"Skvortsova K, Iovino N, Bogdanovi\u0107 O. Functions and mechanisms of epigenetic inheritance in animals. Nat Rev Mol Cell Biol. 2018;19(12):774\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7664","key":"1013_CR89","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nature23262","volume":"547","author":"A Inoue","year":"2017","unstructured":"Inoue A, Jiang L, Lu F, Suzuki T, Zhang Y. Maternal H3K27me3 controls DNA methylation-independent imprinting. Nature. 2017;547(7664):419\u201324.","journal-title":"Nature"},{"issue":"7621","key":"1013_CR90","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nature19360","volume":"537","author":"JA Dahl","year":"2016","unstructured":"Dahl JA, Jung I, Aanes H, Greggains GD, Manaf A, Lerdrup M, Li G, Kuan S, Li B, Lee AY. Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. Nature. 2016;537(7621):548\u201352.","journal-title":"Nature"},{"issue":"2","key":"1013_CR91","doi-asserted-by":"publisher","first-page":"E304","DOI":"10.1210\/jc.2010-1290","volume":"96","author":"L Manner\u00e5s-Holm","year":"2011","unstructured":"Manner\u00e5s-Holm L, Leonhardt H, Kullberg J, Jennische E, Od\u00e9n A, Holm G, Hellstr\u00f6m M, L\u00f6nn L, Olivecrona G, Stener-Victorin E. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab. 2011;96(2):E304\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1013_CR92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"M Kokosar","year":"2016","unstructured":"Kokosar M, Benrick A, Perfilyev A, Fornes R, Nilsson E, Maliqueo M, Behre CJ, Sazonova A, Ohlsson C, Ling C. Epigenetic and transcriptional alterations in human adipose tissue of polycystic ovary syndrome. Sci Rep. 2016;6(1):1\u201318.","journal-title":"Sci Rep"},{"issue":"8","key":"1013_CR93","doi-asserted-by":"publisher","first-page":"e1005455","DOI":"10.1371\/journal.pgen.1005455","volume":"11","author":"MR Jones","year":"2015","unstructured":"Jones MR, Brower MA, Xu N, Cui J, Mengesha E. Chen Y-DI, Taylor KD, Azziz R, Goodarzi MO: Systems genetics reveals the functional context of PCOS loci and identifies genetic and molecular mechanisms of disease heterogeneity. PLoS Genet. 2015;11(8):e1005455.","journal-title":"PLoS Genet"},{"issue":"4","key":"1013_CR94","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.fertnstert.2006.12.055","volume":"88","author":"J-P Baillargeon","year":"2007","unstructured":"Baillargeon J-P, Carpentier A. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertil Steril. 2007;88(4):886\u201393.","journal-title":"Fertil Steril"},{"issue":"12","key":"1013_CR95","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1210\/jc.2018-00935","volume":"103","author":"E Nilsson","year":"2018","unstructured":"Nilsson E, Benrick A, Kokosar M, Krook A, Lindgren E, K\u00e4llman T, Martis MM, H\u00f8jlund K, Ling C, Stener-Victorin E. Transcriptional and epigenetic changes influencing skeletal muscle metabolism in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2018;103(12):4465\u201377.","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"1013_CR96","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.18632\/oncotarget.2224","volume":"5","author":"X-X Wang","year":"2014","unstructured":"Wang X-X, Wei J-Z, Jiao J, Jiang S-Y, Yu D-H, Li D. Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development. Oncotarget. 2014;5(16):6603.","journal-title":"Oncotarget"},{"issue":"4","key":"1013_CR97","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000355314","volume":"76","author":"Y-Y Yu","year":"2013","unstructured":"Yu Y-Y, Sun C-X, Liu Y-K, Li Y, Wang L, Zhang W. Promoter methylation of CYP19A1 gene in Chinese polycystic ovary syndrome patients. Gynecol Obstet Invest. 2013;76(4):209\u201313.","journal-title":"Gynecol Obstet Invest"},{"key":"1013_CR98","doi-asserted-by":"publisher","first-page":"110611","DOI":"10.1016\/j.mce.2019.110611","volume":"500","author":"E Makrinou","year":"2020","unstructured":"Makrinou E, Drong A, Christopoulos G, Lerner A, Chapa-Chorda I, Karaderi T, Lavery S, Hardy K, Lindgren C, Franks S. Genome-wide methylation profiling in granulosa lutein cells of women with polycystic ovary syndrome (PCOS). Mol Cell Endocrinol. 2020;500:110611.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"1013_CR99","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tem.2014.12.004","volume":"26","author":"JM McAllister","year":"2015","unstructured":"McAllister JM, Legro RS, Modi BP, Strauss JF III. Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends Endocrinol Metab. 2015;26(3):118\u201324.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"1013_CR100","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.fertnstert.2009.10.020","volume":"94","author":"N Xu","year":"2010","unstructured":"Xu N, Azziz R, Goodarzi MO. Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation. Fertility and sterility. 2010;94(2):781-783.e781.","journal-title":"Fertility and sterility"},{"issue":"1","key":"1013_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7827-3-44","volume":"3","author":"E Stener-Victorin","year":"2005","unstructured":"Stener-Victorin E, Ploj K, Larsson B-M, Holm\u00e4ng A. Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity. Reprod Biol Endocrinol. 2005;3(1):1\u201310.","journal-title":"Reprod Biol Endocrinol"},{"issue":"7","key":"1013_CR102","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.2337\/diabetes.52.7.1716","volume":"52","author":"T Bock","year":"2003","unstructured":"Bock T, Pakkenberg B, Buschard K. Increased islet volume but unchanged islet number in ob\/ob mice. Diabetes. 2003;52(7):1716\u201322.","journal-title":"Diabetes"},{"issue":"6","key":"1013_CR103","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981\u20131030.","journal-title":"Endocr Rev"},{"issue":"5","key":"1013_CR104","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/jc.2009-2724","volume":"95","author":"RA Wild","year":"2010","unstructured":"Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95(5):2038\u201349.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1013_CR105","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1095\/biolreprod48.1.15","volume":"48","author":"JK Findlay","year":"1993","unstructured":"Findlay JK. An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod. 1993;48(1):15\u201323.","journal-title":"Biol Reprod"},{"issue":"1","key":"1013_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep39638","volume":"6","author":"Q Liu","year":"2016","unstructured":"Liu Q, Li Y, Feng Y, Liu C, Ma J, Li Y, Xiang H, Ji Y, Cao Y, Tong X. Single-cell analysis of differences in transcriptomic profiles of oocytes and cumulus cells at GV, MI, MII stages from PCOS patients. Sci Rep. 2016;6(1):1\u201312.","journal-title":"Sci Rep"},{"issue":"1","key":"1013_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-018-0442-y","volume":"10","author":"J-X Pan","year":"2018","unstructured":"Pan J-X, Tan Y-J, Wang F-F, Hou N-N, Xiang Y-Q, Zhang J-Y, Liu Y, Qu F, Meng Q, Xu J. Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis. Clin Epigenetics. 2018;10(1):1\u201312.","journal-title":"Clin Epigenetics"},{"issue":"11","key":"1013_CR108","doi-asserted-by":"publisher","first-page":"e27286","DOI":"10.1371\/journal.pone.0027286","volume":"6","author":"N Xu","year":"2011","unstructured":"Xu N, Kwon S, Abbott DH, Geller DH, Dumesic DA, Azziz R, Guo X, Goodarzi MO. Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS ONE. 2011;6(11):e27286.","journal-title":"PLoS ONE"},{"issue":"11","key":"1013_CR109","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrendo.2016.157","volume":"12","author":"JA Boyle","year":"2016","unstructured":"Boyle JA, Teede HJ. Refining diagnostic features in PCOS to optimize health outcomes. Nat Rev Endocrinol. 2016;12(11):630\u20131.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"1013_CR110","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):487\u2013525.","journal-title":"Endocr Rev"},{"key":"1013_CR111","unstructured":"Edgar Ricardo V: Yadira In\u00e9s G. V, Elizabeth G-G, Christian R-M, Enrique R-M, Ignacio C-A, et al 2019."},{"issue":"1","key":"1013_CR112","doi-asserted-by":"publisher","first-page":"e14524","DOI":"10.1371\/journal.pone.0014524","volume":"6","author":"F Brenet","year":"2011","unstructured":"Brenet F, Moh M, Funk P, Feierstein E, Viale AJ, Socci ND, Scandura JM. DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS ONE. 2011;6(1):e14524.","journal-title":"PLoS ONE"},{"issue":"1","key":"1013_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13072-018-0205-1","volume":"11","author":"D Anastasiadi","year":"2018","unstructured":"Anastasiadi D, Esteve-Codina A, Piferrer F. Consistent inverse correlation between DNA methylation of the first intron and gene expression across tissues and species. Epigenetics Chromatin. 2018;11(1):1\u201317.","journal-title":"Epigenetics Chromatin"},{"issue":"10","key":"1013_CR114","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"AM Deaton","year":"2011","unstructured":"Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011;25(10):1010\u201322.","journal-title":"Genes Dev"},{"issue":"8","key":"1013_CR115","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00109-012-0881-4","volume":"90","author":"F Qu","year":"2012","unstructured":"Qu F, Wang F-F, Yin R, Ding G-L, El-Prince M, Gao Q, Shi B-W, Pan H-H, Huang Y-T, Jin M. A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J Mol Med. 2012;90(8):911\u201323.","journal-title":"J Mol Med"},{"issue":"10","key":"1013_CR116","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nbt.1678","volume":"28","author":"TK Kelly","year":"2010","unstructured":"Kelly TK, De Carvalho DD, Jones PA. Epigenetic modifications as therapeutic targets. Nat Biotechnol. 2010;28(10):1069\u201378.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"1013_CR117","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrendo.2017.90","volume":"13","author":"SM Reilly","year":"2017","unstructured":"Reilly SM, Saltiel AR. Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol. 2017;13(11):633\u201343.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"1013_CR118","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1210\/jc.2005-2327","volume":"91","author":"F Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez F, Rote NS, Minium J, Kirwan JP. Increased activation of nuclear factor \u03baB triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(4):1508\u201312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1013_CR119","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1210\/jc.2014-2419","volume":"100","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Zhang C, Huang Y, Yu Y, Li R, Li M, Liu N, Liu P, Qiao J. Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3K\/AKT\/NF-\u03baB signaling in the granulosa cells of PCOS patients. J Clin Endocrinol Metab. 2015;100(1):201\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1013_CR120","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MED.0b013e3283339051","volume":"17","author":"M Asmar","year":"2010","unstructured":"Asmar M, Holst JJ. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances. Curr Opin Endocrinol Diabetes Obes. 2010;17(1):57\u201362.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"6","key":"1013_CR121","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","volume":"17","author":"JE Campbell","year":"2013","unstructured":"Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 2013;17(6):819\u201337.","journal-title":"Cell Metab"},{"issue":"3","key":"1013_CR122","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","volume":"3","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ. The biology of incretin hormones. Cell Metab. 2006;3(3):153\u201365.","journal-title":"Cell Metab"},{"issue":"1","key":"1013_CR123","first-page":"41","volume":"56","author":"B Pelusi","year":"2004","unstructured":"Pelusi B, Gambineri A, Pasquali R. Type 2 diabetes and the polycystic ovary syndrome. Minerva Ginecol. 2004;56(1):41\u201351.","journal-title":"Minerva Ginecol"},{"issue":"1","key":"1013_CR124","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","volume":"24","author":"DJ Drucker","year":"2016","unstructured":"Drucker DJ. The cardiovascular biology of glucagon-like peptide-1. Cell Metab. 2016;24(1):15\u201330.","journal-title":"Cell Metab"},{"issue":"1","key":"1013_CR125","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4172\/2155-6156.1000483","volume":"6","author":"RJ Chilton","year":"2015","unstructured":"Chilton RJ. Potential cardiovascular effects of the glucagon-like peptide-1 receptor agonists. J Diabetes Metab. 2015;6(1):483.","journal-title":"J Diabetes Metab"},{"key":"1013_CR126","doi-asserted-by":"publisher","first-page":"100325","DOI":"10.1016\/j.conctc.2019.100325","volume":"14","author":"NI Williams","year":"2019","unstructured":"Williams NI, Mallinson RJ, De Souza MJ. Rationale and study design of an intervention of increased energy intake in women with exercise-associated menstrual disturbances to improve menstrual function and bone health: The REFUEL study. Contemp Clin Trials Commu. 2019;14:100325.","journal-title":"Contemp Clin Trials Commu"},{"issue":"5","key":"1013_CR127","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/GCO.0b013e32835669ff","volume":"24","author":"BW Rackow","year":"2012","unstructured":"Rackow BW. Polycystic ovary syndrome in adolescents. Curr Opin Obstet Gynecol. 2012;24(5):281\u20137.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1013_CR128","unstructured":"V.V Smirnov INV, Bondarev S.A Effects of androgens on bone tissue in female athletes with PCO. Global Reproduction 2021, (1) C 57\u201361"},{"issue":"9","key":"1013_CR129","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1249\/01.MSS.0000084530.31478.DF","volume":"35","author":"MJ De Souza","year":"2003","unstructured":"De Souza MJ. Menstrual disturbances in athletes: a focus on luteal phase defects. Med Sci Sports Exerc. 2003;35(9):1553\u201363.","journal-title":"Med Sci Sports Exerc"},{"issue":"4","key":"1013_CR130","first-page":"340","volume":"42","author":"G Papadakis","year":"2017","unstructured":"Papadakis G, Kandaraki E, Papalou O, Vryonidou A, Diamanti-Kandarakis E. Is cardiovascular risk in women with PCOS a real risk? Current insights Minerva endocrinologica. 2017;42(4):340\u201355.","journal-title":"Current insights Minerva endocrinologica"},{"issue":"07","key":"1013_CR131","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1055\/a-0871-6831","volume":"79","author":"E Arslan","year":"2019","unstructured":"Arslan E, Gorkem U, Togrul C. Is There a Relationship Between Vitamin D Deficiency Status and PCOS in Infertile Women? Geburtshilfe Frauenheilkd. 2019;79(07):723\u201330.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"3","key":"1013_CR132","first-page":"99","volume":"2","author":"N Xu","year":"2015","unstructured":"Xu N, Geller DH, Jones MR, Funari VA, Azziz R, Goodarzi MO. Comprehensive assessment of expression of insulin signaling pathway components in subcutaneous adipose tissue of women with and without polycystic ovary syndrome. J Clin Transl Endocrinol. 2015;2(3):99\u2013104.","journal-title":"J Clin Transl Endocrinol"},{"key":"1013_CR133","doi-asserted-by":"crossref","unstructured":"Tabrizi R, Ostadmohammadi V, Akbari M, Lankarani KB, Vakili S, Peymani P, Karamali M, Kolahdooz F, Asemi Z: The effects of probiotic supplementation on clinical symptom, weight loss, glycemic control, lipid and hormonal profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Probiotics and antimicrobial proteins 2019:1\u201314.","DOI":"10.1007\/s12602-019-09559-0"},{"issue":"4","key":"1013_CR134","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1210\/en.2017-03218","volume":"159","author":"GE Ryan","year":"2018","unstructured":"Ryan GE, Malik S, Mellon PL. Antiandrogen treatment ameliorates reproductive and metabolic phenotypes in the letrozole-induced mouse model of PCOS. Endocrinology. 2018;159(4):1734\u201347.","journal-title":"Endocrinology"},{"issue":"4","key":"1013_CR135","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3109\/09513590.2012.754876","volume":"29","author":"R Paradisi","year":"2013","unstructured":"Paradisi R, Fabbri R, Battaglia C, Venturoli S. Ovulatory effects of flutamide in the polycystic ovary syndrome. Gynecol Endocrinol. 2013;29(4):391\u20135.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"1013_CR136","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/09513590400004736","volume":"19","author":"I Sahin","year":"2004","unstructured":"Sahin I, Serter R, Karakurt F, Demirbas B, Culha C, Taskapan C, Kosar F, Aral Y. Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study. Gynecol Endocrinol. 2004;19(3):115\u201324.","journal-title":"Gynecol Endocrinol"}],"updated-by":[{"DOI":"10.1007\/s43032-022-01035-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000}}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-01013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-022-01013-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-01013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T23:27:54Z","timestamp":1679873274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-022-01013-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":136,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1013"],"URL":"https:\/\/doi.org\/10.1007\/s43032-022-01013-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s43032-022-01035-5","asserted-by":"object"}]},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"assertion":[{"value":"22 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s43032-022-01035-5","URL":"https:\/\/doi.org\/10.1007\/s43032-022-01035-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not involve any animal or human subjects and require no institutional ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}